The government plans to spend nearly $800,000 to determine the strategic importance of nuclear medicine research, according to National Institutes of Health chief Dr. Elias Zerhouni. Society of Nuclear Medicine president Dr. Peter Conti is encouraged about the initiative.
The government plans to spend nearly $800,000 to determine the strategic importance of nuclear medicine research, according to National Institutes of Health chief Dr. Elias Zerhouni. Society of Nuclear Medicine president Dr. Peter Conti is encouraged about the initiative.
"At least it shows that somebody cares about nuclear medicine research and wants to study it. That's a lot better than cuts made because it is thought to have no value," Conti said.
The Department of Energy and the NIH will spend 13 months investigating topics such as radiopharmaceutical development for diagnosis and therapy, software and hardware development for more precise radiotracer localization, hurdles facing the incorporation of new radiopharmaceutical compounds, and strategies to overcome probable shortages of isotopes and qualified researchers.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.